Glanatec,
K-115,
K115 compound,
ripasudil,
887375-67-9,
K-115,
Ripasudil hydrochloride dihydrate,
UNII-016TTR32QF,
016TTR32QF,
Ripasudil hydrochloride hydrate [JAN],
K115,
Ripasudil hydrochloride hydrate (JAN),
Ripasudil hydrochloride hydrate,
Glanatec (TN),
Ripasudil(K-115),
Ripasudil (K-115),
Ripasudil hydrochloride dihydrate [WHO-DD],
Ripasudil (K-115) dihydrate,
BCP11082,
C15H18FN3O2S.ClH.2H2O,
KS-00000LF8,
3757AH,
MFCD26960897,
Ripasudil (K-115) hydrochloride di,
s7995,
CS-3401,
1H-1,4-Diazepine, 1-((4-fluoro-5-isoquinolinyl)sulfonyl)hexahydro-2-methyl-, monohydrochloride, dihydrate, (2S)-,
HY-15685,
Isoquinoline, 4-fluoro-5-(((2S)-hexahydro-2-methyl-1H-1,4-diazepin-1-yl)sulfonyl)-, hydrochloride, hydrate (1:1:2),
Ripasudil (K-115) hydrochloride dihydrate,
D10463,
(S)-4-Fluoro-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline hydrochloride dihydrate,
4-Fluoro-5-[(2S)-2-methyl-1,4-diazepane-1-sulfonyl]isoquinoline dihydrate hydrochloride,
4-fluoro-5-{[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl}isoquinoline dihydrate hydrochloride,
Ripasudil,
ACN-037976,
CID11625386,
B4809,
(S)-4-Fluoro-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline,
4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline Dihydrate Hydrochloride,
Ripasudil (K-115), 98%, a highly selective and potent Rho-kinase inhibitor - 10MG 10mg,
(2S)-1-[(4-Fluoro-5-isoquinolinyl)sulfonyl]hexahydro-2-methyl-1H-1,4-diazepine monohydrochloride dihydrate,
223645-67-8,